 Defective lymphokine-activated killer cell generation activity acute leukemia patients active disease myeloid lymphoid acute leukemia patients presentation capacity lymphokine-activated killer LAK cells effective natural killer NK Raji cell line susceptibility blasts normal peripheral blood PB LAK cells autologous LAK effectors overall PB LAK activity Raji cells acute leukemia patients normal controls SD LAK effectors sensitivity blasts autologous LAK cells normal LAK effectors LAK effectors data patterns behavior group patients effective LAK cells Raji line blasts resistant autologous PB-LAK effectors susceptible normal LAK cells defective specific LAK activity cases incapacity LAK activity allogeneic autologous target cells defective LAK generation cases blasts resistant allogeneic autologous LAK populations latter effective Raji line resistant blasts defects bone marrow-derived LAK cells cases leukemic blasts susceptible autologous allogeneic LAK cells patients analysis remission restoration LAK function primary blasts cases relapse blasts resistant autologous LAK effectors normal LAK data demonstrate acute leukemia patients active disease defect LAK machinery deficient generation LAK cells resistance blasts LAK effectors possible contributory role LAK system control leukemic cell growth view frequent normalization autologous LAK activity time remission immunotherapy cells patients minimal residual disease